Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ziopharm slips on report that co withheld warning on trial data
Reuters
Saturday, October 20, 2012 - 10:31am
tags:
Ziopharm, soft tissue sarcomas, palifosfamide
Biogen slips as FDA extends review of MS drug
Yahoo/AP
Saturday, October 20, 2012 - 10:29am
tags:
Biogen, BG-12, MS, multiple sclerosis
An FDA Decision Is on the MAP
Motley Fool
Saturday, October 20, 2012 - 10:28am
tags:
Levadex, MAP Pharmaceuticals, migraines
CRL/AstraZeneca Join Forces
Yahoo/Zacks
Saturday, October 20, 2012 - 10:27am
tags:
Charles River Laboratories, AstraZeneca
Earnings Beat at Cubist Pharma
Yahoo/Zacks
Saturday, October 20, 2012 - 10:26am
tags:
Cubist Pharmaceuticals, earnings
Amgen's Soaring, but Will Gravity Kick In?
Motley Fool
Saturday, October 20, 2012 - 10:26am
tags:
Amgen
PropThink: PBYI Makes a Big Splash on the NYSE; Why all the Excitement?
Yahoo/Reuters
Saturday, October 20, 2012 - 10:25am
tags:
Puma Biotechnology
Novo's long-acting insulin degludec takes big step to megamarket status
Fierce Biotech
Friday, October 19, 2012 - 12:20pm
tags:
degludec, Novo Nordisk, diabetes, insulin, Europe, Tresiba
Eli Lilly's Amyvid receives recommendation for approval from European committee
Yahoo/AP
Friday, October 19, 2012 - 12:17pm
tags:
Amyvid, Europe, Alzheimer's disease, Eli Lilly
Top 10 Pharma Layoffs of 2012
Fierce Pharma
Friday, October 19, 2012 - 11:46am
tags:
layoffs
Vivus Obesity Drug Fails to Win European Agency Backing
Bloomberg
Friday, October 19, 2012 - 11:45am
tags:
obsesity, Europe, Vivus, Qsiva, Qsymia
Lundbeck in Talks With Possible Alzheimer’s Drug Partners
Bloomberg
Friday, October 19, 2012 - 11:34am
tags:
Lundbeck, Alzheimer's disease, M&A, Acrescent, AE58054
Bristol-Myers Squibb Third Quarter Earnings Preview
Investopedia.com
Friday, October 19, 2012 - 11:33am
tags:
earnings, Bristol-Myers Squibb
ISIS Pharma shares rise after FDA panel backs approval for cholesterol drug Kynamro
Yahoo/AP
Friday, October 19, 2012 - 11:21am
tags:
Isis Pharmaceuticals, FDA, advisory panels, Kynamro
Cubist Pharma 3rd-quarter profit rises on greater Cubicin revenue and lower tax provision
Yahoo/AP
Friday, October 19, 2012 - 11:18am
tags:
earnings, Cubist Pharmaceuticals
Acadia's Bubbling To Move Higher
Seeking Alpha
Friday, October 19, 2012 - 11:17am
tags:
Acadia, pimavanserin, antipsychotics
Common Antidepressants May Raise Stroke Risk a Bit, Study Finds
Medline Plus
Friday, October 19, 2012 - 11:16am
tags:
SSRIs, antidepressants, stroke, Prozac, Paxil, Zoloft, Celexa, Lexapro, Forest Labs, Eli Lilly, Pfizer, GSK
Lipitor's Patent Expiration: How Much Will It Impact Pfizer's Revenue And Earnings In 2012?
Seeking Alpha
Friday, October 19, 2012 - 11:11am
tags:
Lipitor, patents, generics, Pfizer, earnings
Bayer wins EU endorsement for Xarelto in lung embolism
Reuters
Friday, October 19, 2012 - 11:11am
tags:
Europe, Bayer, Xarelto, pulmonary embolism
Eli Lilly Third Quarter Earnings Preview
Investopedia.com
Friday, October 19, 2012 - 11:04am
tags:
Eli Lilly, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.